Global Anti-obesity Medicine Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Prescription Drugs
  • 1.2.3 OTC Drugs
• 1.3 Market by Application
  • 1.3.1 Global Anti-obesity Medicine Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Men
  • 1.3.3 Women
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-obesity Medicine Market Perspective (2016-2027)
• 2.2 Anti-obesity Medicine Growth Trends by Regions
  • 2.2.1 Anti-obesity Medicine Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Anti-obesity Medicine Historic Market Share by Regions (2016-2021)
  • 2.2.3 Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027)
• 2.3 Anti-obesity Medicine Industry Dynamic
  • 2.3.1 Anti-obesity Medicine Market Trends
  • 2.3.2 Anti-obesity Medicine Market Drivers
  • 2.3.3 Anti-obesity Medicine Market Challenges
  • 2.3.4 Anti-obesity Medicine Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Anti-obesity Medicine Players by Revenue
  • 3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2016-2021)
  • 3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2016-2021)
• 3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
• 3.4 Global Anti-obesity Medicine Market Concentration Ratio
  • 3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2020
• 3.5 Anti-obesity Medicine Key Players Head office and Area Served
• 3.6 Key Players Anti-obesity Medicine Product Solution and Service
• 3.7 Date of Enter into Anti-obesity Medicine Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-obesity Medicine Breakdown Data by Type

• 4.1 Global Anti-obesity Medicine Historic Market Size by Type (2016-2021)
• 4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027)

5 Anti-obesity Medicine Breakdown Data by Application

• 5.1 Global Anti-obesity Medicine Historic Market Size by Application (2016-2021)
• 5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Anti-obesity Medicine Market Size (2016-2027)
• 6.2 North America Anti-obesity Medicine Market Size by Type
  • 6.2.1 North America Anti-obesity Medicine Market Size by Type (2016-2021)
  • 6.2.2 North America Anti-obesity Medicine Market Size by Type (2022-2027)
  • 6.2.3 North America Anti-obesity Medicine Market Size by Type (2016-2027)
• 6.3 North America Anti-obesity Medicine Market Size by Application
  • 6.3.1 North America Anti-obesity Medicine Market Size by Application (2016-2021)
  • 6.3.2 North America Anti-obesity Medicine Market Size by Application (2022-2027)
  • 6.3.3 North America Anti-obesity Medicine Market Size by Application (2016-2027)
• 6.4 North America Anti-obesity Medicine Market Size by Country
  • 6.4.1 North America Anti-obesity Medicine Market Size by Country (2016-2021)
  • 6.4.2 North America Anti-obesity Medicine Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Anti-obesity Medicine Market Size (2016-2027)
• 7.2 Europe Anti-obesity Medicine Market Size by Type
  • 7.2.1 Europe Anti-obesity Medicine Market Size by Type (2016-2021)
  • 7.2.2 Europe Anti-obesity Medicine Market Size by Type (2022-2027)
  • 7.2.3 Europe Anti-obesity Medicine Market Size by Type (2016-2027)
• 7.3 Europe Anti-obesity Medicine Market Size by Application
  • 7.3.1 Europe Anti-obesity Medicine Market Size by Application (2016-2021)
  • 7.3.2 Europe Anti-obesity Medicine Market Size by Application (2022-2027)
  • 7.3.3 Europe Anti-obesity Medicine Market Size by Application (2016-2027)
• 7.4 Europe Anti-obesity Medicine Market Size by Country
  • 7.4.1 Europe Anti-obesity Medicine Market Size by Country (2016-2021)
  • 7.4.2 Europe Anti-obesity Medicine Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Anti-obesity Medicine Market Size (2016-2027)
• 8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
  • 8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
  • 8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
  • 8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Anti-obesity Medicine Market Size (2016-2027)
• 9.2 Latin America Anti-obesity Medicine Market Size by Type
  • 9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2016-2021)
  • 9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2022-2027)
  • 9.2.3 Latin America Anti-obesity Medicine Market Size by Type (2016-2027)
• 9.3 Latin America Anti-obesity Medicine Market Size by Application
  • 9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2016-2021)
  • 9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2022-2027)
  • 9.3.3 Latin America Anti-obesity Medicine Market Size by Application (2016-2027)
• 9.4 Latin America Anti-obesity Medicine Market Size by Country
  • 9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2016-2021)
  • 9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Anti-obesity Medicine Market Size (2016-2027)
• 10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
  • 10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
  • 10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
  • 10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Alizyme
  • 11.1.1 Alizyme Company Details
  • 11.1.2 Alizyme Business Overview
  • 11.1.3 Alizyme Anti-obesity Medicine Introduction
  • 11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.1.5 Alizyme Recent Development
• 11.2 Amylin Pharmaceuticals
  • 11.2.1 Amylin Pharmaceuticals Company Details
  • 11.2.2 Amylin Pharmaceuticals Business Overview
  • 11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
  • 11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.2.5 Amylin Pharmaceuticals Recent Development
• 11.3 Arena Pharmaceuticals
  • 11.3.1 Arena Pharmaceuticals Company Details
  • 11.3.2 Arena Pharmaceuticals Business Overview
  • 11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
  • 11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.3.5 Arena Pharmaceuticals Recent Development
• 11.4 Boehringer Ingelheim
  • 11.4.1 Boehringer Ingelheim Company Details
  • 11.4.2 Boehringer Ingelheim Business Overview
  • 11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
  • 11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.4.5 Boehringer Ingelheim Recent Development
• 11.5 Eisai
  • 11.5.1 Eisai Company Details
  • 11.5.2 Eisai Business Overview
  • 11.5.3 Eisai Anti-obesity Medicine Introduction
  • 11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.5.5 Eisai Recent Development
• 11.6 GlaxoSmithKline
  • 11.6.1 GlaxoSmithKline Company Details
  • 11.6.2 GlaxoSmithKline Business Overview
  • 11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
  • 11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.6.5 GlaxoSmithKline Recent Development
• 11.7 Orexigen Therapeutics
  • 11.7.1 Orexigen Therapeutics Company Details
  • 11.7.2 Orexigen Therapeutics Business Overview
  • 11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
  • 11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.7.5 Orexigen Therapeutics Recent Development
• 11.8 Vivus
  • 11.8.1 Vivus Company Details
  • 11.8.2 Vivus Business Overview
  • 11.8.3 Vivus Anti-obesity Medicine Introduction
  • 11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.8.5 Vivus Recent Development
• 11.9 Pfizer
  • 11.9.1 Pfizer Company Details
  • 11.9.2 Pfizer Business Overview
  • 11.9.3 Pfizer Anti-obesity Medicine Introduction
  • 11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.9.5 Pfizer Recent Development
• 11.10 Roche
  • 11.10.1 Roche Company Details
  • 11.10.2 Roche Business Overview
  • 11.10.3 Roche Anti-obesity Medicine Introduction
  • 11.10.4 Roche Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.10.5 Roche Recent Development
• 11.11 Merck
  • 11.11.1 Merck Company Details
  • 11.11.2 Merck Business Overview
  • 11.11.3 Merck Anti-obesity Medicine Introduction
  • 11.11.4 Merck Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.11.5 Merck Recent Development
• 11.12 Novo Nordisk
  • 11.12.1 Novo Nordisk Company Details
  • 11.12.2 Novo Nordisk Business Overview
  • 11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
  • 11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021)
  • 11.12.5 Novo Nordisk Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer